MAP2K7 and acquired polycythemia vera: In fact, survival of PV was more sensitive than AB not only to JAK/STAT inhibitors but also to inhibitors of cKIT and MEK (which is upstream of ERK1/2) and of CD63 suggesting that further endeavors to treat the disease should be focused either on MEK inhibitors or CD63 antibodies (53).